Tuesday, February 28, 2017

Valeant's Revenue Falls 13%

Valeant Pharmaceuticals said its revenue fell 13% in the fourth quarter, hurt by the performance of the stomach-drug business it tried to sell late last year as well as lower drug prices.

from WSJ.com: US Business http://ift.tt/2luIMKC
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)